These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2682005)

  • 1. Ras gene activation and epidermal growth factor receptor expression in human colon cancer.
    Ravikumar TS; Wolf B; Cocchiaro C; D'Emilia J; Steele G
    J Surg Res; 1989 Nov; 47(5):418-22. PubMed ID: 2682005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human bladder and colon carcinomas contain activated ras p21. Specific detection of twelfth codon mutants.
    Meyers FJ; Gumerlock PH; Kokoris SP; deVere White RW; McCormick F
    Cancer; 1989 Jun; 63(11):2177-81. PubMed ID: 2655864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. K-ras mutations in putative preneoplastic lesions in human colon.
    Pretlow TP; Brasitus TA; Fulton NC; Cheyer C; Kaplan EL
    J Natl Cancer Inst; 1993 Dec; 85(24):2004-7. PubMed ID: 8246286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ras oncogene p21 levels parallel malignant potential of different human colonic benign conditions.
    Michelassi F; Leuthner S; Lubienski M; Bostwick D; Rodgers J; Handcock M; Block GE
    Arch Surg; 1987 Dec; 122(12):1414-6. PubMed ID: 3318757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent mutations of K-ras oncogene at codons 12 and 22 in colon cancer.
    Miyakura Y; Sugano K; Fukayama N; Konishi F; Nagai H
    Jpn J Clin Oncol; 2002 Jun; 32(6):219-21. PubMed ID: 12110640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. K-ras gene mutations in normal colorectal tissues from K-ras mutation-positive colorectal cancer patients.
    Zhu D; Keohavong P; Finkelstein SD; Swalsky P; Bakker A; Weissfeld J; Srivastava S; Whiteside TL
    Cancer Res; 1997 Jun; 57(12):2485-92. PubMed ID: 9192830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalized cancer treatment and the myth of KRAS wild-type colon tumors.
    Parsons BL; Myers MB
    Discov Med; 2013 Apr; 15(83):259-67. PubMed ID: 23636143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational and nonmutational activation of p21ras in rat colonic azoxymethane-induced tumors: effects on mitogen-activated protein kinase, cyclooxygenase-2, and cyclin D1.
    Bissonnette M; Khare S; von Lintig FC; Wali RK; Nguyen L; Zhang Y; Hart J; Skarosi S; Varki N; Boss GR; Brasitus TA
    Cancer Res; 2000 Aug; 60(16):4602-9. PubMed ID: 10969813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Markers for EGFR pathway activation as predictor of outcome in metastatic colorectal cancer patients treated with or without cetuximab.
    Tol J; Dijkstra JR; Klomp M; Teerenstra S; Dommerholt M; Vink-Börger ME; van Cleef PH; van Krieken JH; Punt CJ; Nagtegaal ID
    Eur J Cancer; 2010 Jul; 46(11):1997-2009. PubMed ID: 20413299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RAS transformation causes sustained activation of epidermal growth factor receptor and elevation of mitogen-activated protein kinase in human mammary epithelial cells.
    Martínez-Lacaci I; Kannan S; De Santis M; Bianco C; Kim N; Wallace-Jones B; Ebert AD; Wechselberger C; Salomon DS
    Int J Cancer; 2000 Oct; 88(1):44-52. PubMed ID: 10962438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microsatellite alterations and K-ras, TGFbetaRII, IGFRII and bax mutations in sporadic cancers of the gastrointestinal tract.
    Caligo MA; Ghimenti C; Sensi E; Marchetti A; Bertacca G; Giulianotti PG; Fornaciari G; Bevilacqua G
    Oncol Rep; 2000; 7(6):1371-5. PubMed ID: 11032947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation between the presence of Kras mutation and the presence of the proteins epiregulin and amphiregulin in colon cancer tissue].
    Levi Y; Barshack I; Avivi K; Bar-ILan D; Gutman M; Aderka D; Berger R; Yacobi R
    Harefuah; 2013 Jun; 152(6):326-9, 369. PubMed ID: 23885463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of K-ras mutations with p16 methylation in human colon cancer.
    Guan RJ; Fu Y; Holt PR; Pardee AB
    Gastroenterology; 1999 May; 116(5):1063-71. PubMed ID: 10220498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between dietary intake and Ki-ras mutations in colon tumors: a population-based study.
    Slattery ML; Curtin K; Anderson K; Ma KN; Edwards S; Leppert M; Potter J; Schaffer D; Samowitz WS
    Cancer Res; 2000 Dec; 60(24):6935-41. PubMed ID: 11156393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of anti-ras Mr 21,000 protein monoclonal antibodies and immunohistochemical analyses on expression of ras genes in human stomach and thyroid cancers.
    Yoshida K; Hamatani K; Koide H; Ikeda H; Nakamura N; Akiyama M; Tsuchiyama H; Nakayama E; Shiku H
    Cancer Res; 1988 Oct; 48(19):5503-9. PubMed ID: 3046740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mutations of APC and K-ras gene in aberrant crypt foci from human colon].
    Yuan P; Sun M; Zhang J; Zhu X; Shi D
    Zhonghua Bing Li Xue Za Zhi; 2001 Feb; 30(1):35-8. PubMed ID: 11866955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer.
    Linardou H; Dahabreh IJ; Kanaloupiti D; Siannis F; Bafaloukos D; Kosmidis P; Papadimitriou CA; Murray S
    Lancet Oncol; 2008 Oct; 9(10):962-72. PubMed ID: 18804418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. K-Ras, intestinal homeostasis and colon cancer.
    Goel S; Huang J; Klampfer L
    Curr Clin Pharmacol; 2015; 10(1):73-81. PubMed ID: 24219000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a novel oncogenic K-ras mutation in colon cancer.
    Akagi K; Uchibori R; Yamaguchi K; Kurosawa K; Tanaka Y; Kozu T
    Biochem Biophys Res Commun; 2007 Jan; 352(3):728-32. PubMed ID: 17150185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. beta-Catenin mutation is selected during malignant transformation in colon carcinogenesis.
    Yamada Y; Oyama T; Hirose Y; Hara A; Sugie S; Yoshida K; Yoshimi N; Mori H
    Carcinogenesis; 2003 Jan; 24(1):91-7. PubMed ID: 12538353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.